Published on
June 23, 2026
- 11:30 GMT
RenaissThera Raises Arali Ventures-Led Seed Round to Advance its Obesity and Type II Diabetes Pipeline
Funding will accelerate development of therapies targeting Obesity and Type II Diabetes BENGALURU, KARNATAKA, INDIA, June 23, 2026 /EINPresswire.com/ -- RenaissThera Private Limited, a biotechnology company focused on developing innovative and …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
